For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
Immuneering Corp (NASDAQ: IMRX) closed the day trading at $1.82 down -23.21% from the previous closing price of $2.37. In other words, the price has decreased by -$23.21 from its previous closing price. On the day, 22.44 million shares were traded.
Ratios:
For a better understanding of IMRX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.48 and its Current Ratio is at 7.48. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.09.
On March 15, 2024, Needham reiterated its Buy rating and also upped its target price recommendation from $20 to $15.
Stock Price History:
Over the past 52 weeks, IMRX has reached a high of $3.83, while it has fallen to a 52-week low of $1.00. The 50-Day Moving Average of the stock is 19.02%, while the 200-Day Moving Average is calculated to be -1.18%.
Shares Statistics:
A total of 35.99M shares are outstanding, with a floating share count of 25.96M. Insiders hold about 27.87% of the company’s shares, while institutions hold 12.50% stake in the company.
